Tanaka M, Suzuki Y, Takaoka K, Murakami S, Suzuki N, Shimazaki J
Department of Urology, Asahi General Hospital, Chiba, Japan.
Int J Urol. 1999 Dec;6(12):600-6. doi: 10.1046/j.1442-2042.1999.00118.x.
Ratio of free to total (F/T) prostate-specific antigen (PSA) is higher in the blood of patients with benign prostatic hyperplasia than those with prostate cancer. To clarify the difference between ratios in these two, alpha-1-antichymotrypsin, the major component of the bound PSA in the blood, was immunohistochemically examined.
Tissues were obtained surgically via a retropubic approach from patients with benign prostatic hyperplasia (nine cases) and prostate cancer (27 cases). These samples were processed in paraffin blocks, cut into 5 mm sections and stained with antibodies against alpha-1-antichymotrypsin and PSA.
The percentage of alpha-1-antichymotrypsin-stained cells in prostate cancer was higher than that in benign prostatic hyperplasia (P<0.05). Almost all of glandular and cancer cells were stained with PSA antibody. The percentage of alpha-1-antichymotrypsin-stained cells in prostate cancer did not correlate to histologic grade, although alpha-1-antichymotrypsin-stained cells were more widely scattered in high grade tissues. No correlation was found between alpha-1-antichymotrypsin-stained cells and ratio of F/T in the blood of cancer patients. In about 20% of cancer tissues, histiocytes with positive alpha-1-antichymotrypsin staining were found in stroma but not in that of benign prostatic hyperplasia.
Prostate cancer tissues are shown to have a richer environment of alpha-1-antichymotrypsin than those of benign prostatic hyperplasia. Some cancer tissues contained alpha-1-antichymotrypsin-stained histiocytes. These local events may correlate to a high amount of the bound form among total PSA in the blood of prostate cancer patients.
良性前列腺增生患者血液中游离前列腺特异性抗原(PSA)与总PSA的比值(F/T)高于前列腺癌患者。为明确二者比值的差异,对血液中结合型PSA的主要成分α-1-抗糜蛋白酶进行了免疫组织化学检测。
通过耻骨后途径手术获取良性前列腺增生患者(9例)和前列腺癌患者(27例)的组织。将这些样本制成石蜡块,切成5毫米切片,并用抗α-1-抗糜蛋白酶和PSA的抗体进行染色。
前列腺癌中α-1-抗糜蛋白酶染色细胞的百分比高于良性前列腺增生(P<0.05)。几乎所有腺细胞和癌细胞均被PSA抗体染色。前列腺癌中α-1-抗糜蛋白酶染色细胞的百分比与组织学分级无关,尽管α-1-抗糜蛋白酶染色细胞在高级别组织中分布更广泛。在癌症患者血液中,α-1-抗糜蛋白酶染色细胞与F/T比值之间未发现相关性。在约20%的癌组织中,间质中发现α-1-抗糜蛋白酶染色阳性的组织细胞,而良性前列腺增生组织中未发现。
前列腺癌组织中α-1-抗糜蛋白酶的环境比良性前列腺增生组织更丰富。一些癌组织含有α-1-抗糜蛋白酶染色的组织细胞。这些局部情况可能与前列腺癌患者血液中总PSA中结合型PSA含量高有关。